AMENDMENT #1
Published: 08/23/2013
Description
Questions?&?Answers? Attachment?1? Solicitation?13?223?SOL?00102? Amendment?0001? Evaluation?of?Clinical?and?Safety?Outcomes?Associated?with?Conversion?from?Brand? Name?to?Generic?Tacrolimus?products?in?high?risk?Transplant?Recipients? ? ? 1.?Ques...
